Metis Labortories entered the industry of Research Institute in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 9999900, which describes it as a Research Institute. For further clarification, the SIC classifies this business under the code 8733 and described it as a Research Institute. The business provides service to the B2B market.
To acquire more information, please contact Elias Dimitrakakis by calling (631) 284-9757 during business hours. You can also write to the business’ Single Location at 4603 Middle Country Road, Calverton, New York NY 11933. You can also visit the company’s website at invivopharm.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Metis Labortories |
| Representative: | Elias Dimitrakakis |
| Place of Business: | 4603 Middle Country Road, Calverton, NY 11933 |
| Contact Number: | (631) 284-9757 |
| Website: | invivopharm.com |
| Type of Service: | Research Institute |
| SIC Number: | 8733 |
| NAICS Number: | 9999900 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2013 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Metis Labortories is a company operating from Suffolk, New York providing professional Research Institute and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8733 as Research Institute, and with the NAICS code 9999900 as Research Institute.
With a current employee count of 1 to 4, Metis Labortories has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Elias Dimitrakakis at (631) 284-9757 for related queries, or to locate its Single Location using the coordinates 40.92808,-72.78654.
The Single Location can also be found at the street address 4603 Middle Country Road in Calverton, New York 11933 and can be engaged online through the company website at invivopharm.com, the company Twitter , and Facebook page .